![Rajiv Sarman Shukla](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rajiv Sarman Shukla
Plus aucun poste en cours
Fortune : 28 848 $ au 30/06/2026
Profil
Rajiv Sarman Shukla was the founder of Constellation Alpha Capital Corp., founded in 2015, where the title held was Chairman & Chief Executive Officer from 2017 to 2019.
Former jobs include Chief Executive Officer at Swan Defence & Heavy Industries Ltd. from 2013 to 2015, Chairman & Chief Executive Officer at Venturcap Financial Group LLC from 2017 to 2019, Chairman & Chief Executive Officer at Alpha Healthcare Acquisition Corp., Chairman & Chief Executive Officer at Alpha Healthcare Acquisition Corp.
III, Executive Chairman & Chief Executive Officer at Longevity Health Holdings, Inc. from 2025 to 2026, Senior Director at Pfizer Inc. from 2001 to 2006, Independent Director at OcuNexus Therapeutics, Inc., Director at Malladi Drugs & Pharmaceuticals Ltd., Avantor Performance Materials India Pvt Ltd., Arch Pharmalabs Ltd., Unimark Remedies Ltd., Bharat Biotech International Ltd., I-VEN Medi-care India Pvt Ltd., Swiss Bio Pharma Pvt Ltd., and Humacyte, Inc. from 2021 to 2024, Executive Director at Avendus Capital Pvt Ltd., Portfolio Manager at Morgan Stanley Investment Management Pvt Ltd., and Principal at ICICI Venture Funds Management Co. Ltd. Education includes graduate degree from Harvard University and undergraduate degrees from Indian Institute of Technology Madras and Banaras Hindu University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/03/2025 | 110 954 ( 4,48% ) | 28 848 $ | 30/06/2026 |
Anciens postes connus de Rajiv Sarman Shukla
| Sociétés | Poste | Fin |
|---|---|---|
| LONGEVITY HEALTH HOLDINGS, INC. | Directeur Général | 16/03/2026 |
| HUMACYTE, INC. | Directeur/Membre du Conseil | 11/06/2024 |
Constellation Alpha Capital Corp.
 Constellation Alpha Capital Corp. Financial ConglomeratesFinance Operates as a black check company | Directeur Général | 01/08/2019 |
Venturcap Financial Group LLC | Directeur Général | 01/01/2019 |
| SWAN DEFENCE AND HEAVY INDUSTRIES LIMITED | Directeur Général | 01/05/2015 |
Formation de Rajiv Sarman Shukla
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, commercializes and manufactures therapeutic products for clinical ophthalmology | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Morgan Stanley Investment Management Pvt Ltd.
 Morgan Stanley Investment Management Pvt Ltd. Investment Banks/BrokersFinance MSIM emphasizes the exchange of investment ideas among team members and uses intense bottom-up fundamental research to fully understand the industries and companies they invest in. As such, the investment teams draw upon the collective knowledge of portfolio managers and research analysts that have developed expertise in specific sectors, across the market cap spectrum. MSIM's portfolios use four traits to analyze future price trends. These are the lowest p/e ratio, the lowest price-to-book ratio, the lowest price-to-value (calculated by a dividend discount model) and the highest dividend yield. Other appraisal ratios (cash flow ratio, sales-to-price ratio) are also used to a lesser degree. In the investment process, quantitative conclusions about stocks are limited by the effectiveness of financial accounting statements. The firm uses their experience in interpreting financial statements when they design quantitative models. Diversification is used to neutralize the occasional incorrect valuation of a company due to misleading accounting. The portfolio management teams have ultimate responsibility for the construction of portfolios. The team structure maximizes each team member's contribution to the investment process, while ensuring that a senior investor is at all times accountable for final decisions. | Finance |
ICICI Venture Funds Management Co. Ltd.
 ICICI Venture Funds Management Co. Ltd. Investment ManagersFinance ICICI Venture invests in companies located in the Indian market. The firm invests across a broad base of industries including Information Technology, Life Sciences and Healthcare, Media & Entertainment, Banking & Financial Services, Infrastructure, Retail, Aviation, Auto Components, Construction services, Real Estate, Biotechnology, Textiles, Fine Chemicals, Consumer Products, Logistics, etc. They provide financing for buyout transactions. | Finance |
Malladi Drugs & Pharmaceuticals Ltd.
 Malladi Drugs & Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures active pharmaceutical ingredients | Health Technology |
Indian Institute of Technology Madras
 Indian Institute of Technology Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Banaras Hindu University
 Banaras Hindu University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reliance Naval & Engineering Ltd.
 Reliance Naval & Engineering Ltd. Trucks/Construction/Farm MachineryProducer Manufacturing Provides ship building and repair services | Producer Manufacturing |
Avantor Performance Materials India Ltd.
 Avantor Performance Materials India Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Arch Pharmalabs Ltd.
 Arch Pharmalabs Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Unimark Remedies Ltd.
 Unimark Remedies Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets generic medicines | Health Technology |
Avendus Capital Pvt Ltd.
 Avendus Capital Pvt Ltd. Financial ConglomeratesFinance Operates as a financial services firm that offers asset management, investment banking and wealth management solutions | Finance |
Bharat Biotech International Ltd.
 Bharat Biotech International Ltd. BiotechnologyHealth Technology Engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics | Health Technology |
I-VEN Medi-care India Pvt Ltd.
 I-VEN Medi-care India Pvt Ltd. MiscellaneousMiscellaneous Operates as a holding comapny | Miscellaneous |
Swiss Bio Pharma Pvt Ltd. | |
Constellation Alpha Capital Corp.
Constellation Alpha Capital Corp. Financial ConglomeratesFinance Operates as a black check company | Finance |
Venturcap Financial Group LLC | Finance |
Alpha Healthcare Acquisition Corp.
 Alpha Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Alpha Healthcare Acquisition Corp. III
 Alpha Healthcare Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
Humacyte, Inc.
 Humacyte, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Carmell Therapeutics Corp.
 Carmell Therapeutics Corp. Financial ConglomeratesFinance Manufactures cosmetics | Finance |
